First Time Loading...

UG Healthcare Corporation Ltd
SGX:8K7

Watchlist Manager
UG Healthcare Corporation Ltd Logo
UG Healthcare Corporation Ltd
SGX:8K7
Watchlist
Price: 0.112 SGD
Updated: Apr 25, 2024
Section:
 

Wall Street
Price Targets

8K7 Price Targets Summary
UG Healthcare Corporation Ltd

Wall Street analysts forecast 8K7 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 8K7 is 0.2 SGD .

8K7 Lowest Forecast
Wall Street Target
Not Available
8K7 Average Forecast
Wall Street Target
0.2 SGD
79% Upside
8K7 Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
0.2 SGD
79% Upside
Highest
Price Target
Not Available
UG Healthcare Corporation Ltd Competitors:
Price Targets
7447
Nagaileben Co Ltd
12% Downside
ESTA
Establishment Labs Holdings Inc
26% Upside
MED
Medartis Holding AG
31% Upside
COO
Cooper Companies Inc
23% Upside
7447
Nagaileben Co Ltd
12% Downside
ESTA
Establishment Labs Holdings Inc
26% Upside
MED
Medartis Holding AG
31% Upside
COO
Cooper Companies Inc
23% Upside
P
6491
Pegavision Corp
10% Downside
XRAY
DENTSPLY SIRONA Inc
22% Upside
7979
Shofu Inc
1% Downside
300832
Shenzhen New Industries Biomedical Engineering Co Ltd
27% Upside

Revenue
Forecast

Revenue Estimate
UG Healthcare Corporation Ltd

For the last 6 years the compound annual growth rate for UG Healthcare Corporation Ltd's revenue is 8%. The projected CAGR for the next 2 years is 44%.

8%
Past Growth
44%
Estimated Growth
Estimates Accuracy
4%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
UG Healthcare Corporation Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
UG Healthcare Corporation Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

See Also

Summary
8K7 intrinsic value, competitors valuation, and company profile.
DCF Valuation
8K7 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
8K7 stock valuation using valuation multiples.
Wall Street Estimates
8K7 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
8K7 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 8K7's stock price target?
Price Target
0.2 SGD

According to Wall Street analysts, the average 1-year price target for 8K7 is 0.2 SGD .

What is UG Healthcare Corporation Ltd's Revenue forecast?
Projected CAGR
44%

For the last 6 years the compound annual growth rate for UG Healthcare Corporation Ltd's revenue is 8%. The projected CAGR for the next 2 years is 44%.

ALPHA SPREAD
Join more than 131,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.